Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pd-1 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT06310915
What this trial is testing

Oral Chemotherapeutic Drugs Were Analyzed in Patients With Driver Gene Negative Locally Advanced/Advanced Non-small Cell Lung Cancer With PS Score 2 A Prospective, Single-arm, Multicenter, Observational Study on the Efficacy and Safety of Radiochemotherapy Combined With PD-1 Inhibitor

Who this might be right for
Non-small Cell Lung Cancer Stage IIIB/IV
Guangzhou Institute of Respiratory Disease 30
Testing effectiveness (Phase 2)UnknownNCT05420584
What this trial is testing

Neoadjuvant Arterial Embolization Chemotherapy Combined PD-1 Inhibitor for Locally Advanced Rectal Cancer

Who this might be right for
Rectal Neoplasms
The Fourth Affiliated Hospital of Zhejiang University School of Medicine 83
Large-scale testing (Phase 3)UnknownNCT03605706
What this trial is testing

A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With FOLFOX4 in Subjects With Advanced HCC Who Have Never Received Prior Systemic Treatment.

Who this might be right for
Advanced Hepatocellular Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 396
Large-scale testing (Phase 3)Ended earlyNCT02967692
What this trial is testing

The Anti-PD1 Antibody PDR001, in Combination With Dabrafenib and Trametinib in Advanced Melanoma

Who this might be right for
Melanoma
Novartis Pharmaceuticals 568
Not applicableLooking for participantsNCT04615988
What this trial is testing

Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors

Who this might be right for
ThyroidPD-1Cancer
Icahn School of Medicine at Mount Sinai 17
Not applicableStudy completedNCT06900686
What this trial is testing

Clinical Application of PD-1 Inhibitor in Colorectal Cancer for Improving Survival

Who this might be right for
Rectal CancerColon Cancer
Yanhong Deng 458
Testing effectiveness (Phase 2)Looking for participantsNCT07699939
What this trial is testing

Perioperative HLX10 (Serplulimab) With S-1+Oxaliplatin (SOX) in Locally Advanced and PD-L1-Positive Gastric or Esophagogastric Junction Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction (GEJ) Adenocarcinoma
National Cancer Center, Japan 136
Testing effectiveness (Phase 2)Looking for participantsNCT07279077
What this trial is testing

Node-Sparing Low-Dose Radiotherapy Concurrent With Chemotherapy and PD-1 Inhibitor in pMMR/MSS High-Risk Locally Advanced Colon Cancer: A Prospective, Single-Arm, Phase II Trial

Who this might be right for
Colon CancerNeoadjuvant TherapiesImmune Checkpoint Therapy+1 more
Sixth Affiliated Hospital, Sun Yat-sen University 38
Not applicableLooking for participantsNCT07775820
What this trial is testing

PD-L1 Inhibitor Rechallenge After Immunotherapy-Related Pneumonitis in Patients With Lung Cancer

Who this might be right for
Lung CancerRechallengeCheckpoint Inhibitor Pneumonitis
Nanfang Hospital, Southern Medical University 150
Testing effectiveness (Phase 2)UnknownNCT06543836
What this trial is testing

CtDNA-guided Treatment of TKI Plus PD-1 Inhibitor for Advanced pMMR/MSS Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 68
Testing effectiveness (Phase 2)Looking for participantsNCT06284590
What this trial is testing

Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination With Pembrolizumab, in Unresectable Melanoma Patients

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
Philogen S.p.A. 162
Testing effectiveness (Phase 2)UnknownNCT05962450
What this trial is testing

Adoptive Autologous iNKT Cells for the Treatment of Progressed Hepatocellular Carcinoma Continuing on PD-1 Inhibitor Therapy

Who this might be right for
Hepatocellular Carcinoma
Beijing YouAn Hospital 84
Not applicableNot Yet RecruitingNCT06607926
What this trial is testing

Neoadjuvant With Tα1 Plus Immuno-chemotherapy for Resectable NSCLC

Who this might be right for
Resectable Non-Small-Cell Lung Cancer
Xuanwu Hospital, Beijing 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07678580
What this trial is testing

Neoadjuvant Short-Course Radiotherapy Plus Tislelizumab and Chemotherapy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Tang-Du Hospital 50
Large-scale testing (Phase 3)Study completedNCT02973789
What this trial is testing

Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)

Who this might be right for
Nonsmall Cell Lung CancerNSCLC
NovoCure GmbH 291
Large-scale testing (Phase 3)Not Yet RecruitingNCT07551479
What this trial is testing

SCRT Based iTNT vs. LCRT Based TNT for MSS Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer (LARC)MSS (Microsatellite Stable)
Fudan University 612
Early research (Phase 1)UnknownNCT05675462
What this trial is testing

Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib as Second-line or Later Therapy in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Fudan University 25
Testing effectiveness (Phase 2)UnknownNCT05803915
What this trial is testing

Neoadjuvant Toripalimab Plus Nimotuzumab in Oral Squamous Cell Carcinoma Prior to Radical Therapy

Who this might be right for
Oral Squamous Cell Carcinoma
Peking Union Medical College Hospital 57
Testing effectiveness (Phase 2)Active Not RecruitingNCT03516279
What this trial is testing

Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease

Who this might be right for
Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveMinimal Residual Disease
ECOG-ACRIN Cancer Research Group 40
Testing effectiveness (Phase 2)Study completedNCT03190174
What this trial is testing

Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers

Who this might be right for
Ewing SarcomaPEComaEpithelioid Sarcoma+11 more
Sarcoma Oncology Research Center, LLC 34
Next Page